Supplementary Figures
OLA1 does not associate with the cap-binding pp y g ( ) p g complex as assessed by the m 7 -GTP-sepharose pull-down assay. Total cell lysates prepared from HEK-293T or HeLa cells were incubated with m 7 -GTP-sepharose 4B beads or control sepharose beads, and the pull-down products were immunoblotted with anti-OLA1 and anti-eIF4E antibodies. The successful pull-down of eIF4E validated the assay. (B) The enhanced binding of endogenously expressed OLA1 and eIF2α under amino acid starvation. HEK-293T cells were cultured in complete medium or the Krebs-Ringer Bicarbonate Buffer for 1 h and the cell lysates were immunoprecipitated with anti-eIF2α antibody or a control antibody (IgG) and the precipitates were immunoblotted with anti-OLA1 and anti-eIF2α antibody. Note that a non-specific protein was present with the IgG IP with a molecular weight slightly larger than OLA1. (C) OLA1 binds eIF2α in vitro. Recombinant human HIS-eIF2α and OLA1 proteins were co-incubated and immunoprecipitated with anti-eIF2α antibody. The precipitates were then analyzed by immunoblotting with anti-OLA1 and anti-eIF2α antibody (upper panel). The 'input' OLA1 and eIF2α Phosphorylation of the eIF2α present within the rabbit reticulocyte lysate was evaluated with immunoblotting analysis with an anti-eIF2α antibody that cross-reacts with the rabbit protein. The assay shows that none of the OLA1 proteins (OLA1-WT, OLA1-N230A, or ΔTGS), or the control protein RFP, could phosphorylate eIF2α or affect the ability of added PERK to phosphorylate eIF2α. (Protein concentration = 400nM). (E) Effect of OLA1 on in vitro dephosphorylation of eIF2α by PP1. Heavily phosphorylated eIF2α was prepared by incubating dephosphorylation of eIF2α by PP1. Heavily phosphorylated eIF2α was prepared by incubating purified eIF2 with PKR. De-phosphorylation of p-eIF2α was mediated by addition of recombinant PP1 in the presence or absence of OLA1 for the indicated time. The p-eIF2α and total eIF2α were detected by immunoblotting and quantified by densitometry analysis (inset on the right). shCTL and shOLA1 cells of HeLa origin were transfected with Flag-only or FLAG-resOLA1 plasmids for 48h, then treated with 2 μg/ml TM. Cells were subjected to immunoblotting with the indicated antibodies with β-actin used as the loading control. 
test was tested). (F)
Kaplan-Meier analysis for overall survival. OLA1 mRNA level was scored (0 for low expression and 1 for high expression) based on its mean value in all breast cancer patients. p=0.103. 
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